Millennium Initiates First Clinical Trial with the First Oral Proteasome Inhibitor

News   Nov 25, 2009

 
Millennium Initiates First Clinical Trial with the First Oral Proteasome Inhibitor
 
 
 

RELATED ARTICLES

Sartorius Stedim Biotech and Siemens Sign Automation Agreement

News

Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.

READ MORE

Algorithm Helps Diagnose Zika Using Biomarkers

News

A platform that can diagnose several diseases with a high degree of precision using metabolic markers found in patients’ blood has been developed by scientists at the University of Campinas (UNICAMP) in Brazil.

READ MORE

Mechanism by Which Alpha Synuclein Causes Cell Death in Parkinson's Identified

News

Detailed brain cell analysis has helped researchers uncover new mechanisms thought to underlie Parkinson's disease.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy